Back

Risk of heart failure related to non - ergot derived dopaminergic agonists in Parkinson disease. A meta-analysis of randomized controlled trials

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Drug therapy, other Drug therapy, other HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Mrs Carmelina Ariano

Elena d'Aosta Hospital, Naples (Italy)

9 More presentations in this session

Presentation thumbnail
Assessment of the use of ESC heart failure guideline recommended therapy among patients followed at a heart failure outpatient clinic participating in the ESC Heart Failure long-term Registry
Doctor B. Muk (Budapest, HU)
Abstract
Presentation thumbnail
Long-term follow up of hospitalized patients with systolic heart failure undergoing early treatment with beta-blockers more ivabradine: a randomized study
Doctor F. Hidalgo Lesmes (Cordoba, ES)
Abstract
Presentation thumbnail
Comparison of perindopril-amlodipine and losartan-amlodipine combinations in the management of hypertension in patients with metabolic syndrome
Doctor J. Uzokov (Tashkent, UZ)
Presentation thumbnail
How do we use anticoagulation therapy in the era of novel drugs - results of FIRST II registryy
Doctor T. Nociarova (Brno, CZ)
Abstract
Presentation thumbnail
Cardioprotective effects of long-term high-dose therapy with atorvastatin in patients with STEMI in the prevention of chronic heart failure
Professor V. Oleinikov (Penza, RU)

Access the full session

Session thumbnail
Poster Session 3 - Drug therapy, other

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources